“It's clear that what the NSABB was, and what it may be will be very different. The billion-dollar question is whether science, the government and most of all, citizens, will be lesser served. I'm afraid so.”
"If we’ve got lab problems in our best labs, does anyone really expect that the other labs of the world are going to do any better in terms of lab safety?”
"The last place you want to be mixing up samples is in influenza. The ability for that to jump from the lab bench to the community is substantially greater."
"MERS is not a Kingdom of Saudi Arabia problem, and it's not a Middle East problem, it's an international problem—and it takes an international response to deal with it."
"I think whatever the explanation was for adding these new cases it is not good. It’s either a lack of a competent surveillance system or an intentional effort to report fewer cases.”
"If one of those infected people gets on a plane and lands in London, Toronto, New York or Hong Kong and transmits [MERS] to another 30 people, everyone will have a different view."
"One of the problems we have with a MERS-like illness is that it also is very similar to a lot of early-onset illnesses from other respiratory pathogens. So you might very well think of it as influenza or some other respiratory pathogen."